FeaturedPsychology·January 8, 2014·3 min readScientists Find a New Mechanism Underlying DepressionChanges in microglia underlie depressive symptoms brought on by exposure to chronic stress, a new study reports.Read More
FeaturedNeuroscienceOpen Neuroscience ArticlesPsychology·May 30, 2019·4 min read‘Ecstasy’ shows promise for post-traumatic stress treatmentMDMA shows promise for the treatment of post-traumatic stress disorder. Combining the use of Ecstasy with psychotherapy treatments resulted in a reduction of PTSD symptoms after just one session. 54% of the study participants no longer met the PTSD criteria after two sessions. Patients also reported improvements in depression symptoms.Read More
FeaturedGeneticsOpen Neuroscience Articles·October 16, 2013·6 min read‘Individualized’ Therapy for the Brain Targets Specific Gene Mutations Causing Dementia and ALSUsing neurons created from iPS cells derived from people with ALS, researchers develop a new drug which appears to halt the impact of the genetic mutations in some forms of ALS and dementia.Read More
FeaturedNeuroscienceOpen Neuroscience Articles·February 2, 2017·5 min read‘Synthetic Marijuana’ Linked to Serious Health ProblemsResearchers report synthetic marijuana products, sold under names such as K2 or Spice, have serious side effects including psychosis, seizures and even death. Researchers warn they are not a safe substitute for cannabis.Read More
FeaturedNeuroscience·July 10, 2013·4 min read‘Bath Salts’ Stimulant Could Be More Addictive than MethA new study confirms MDPV, a recreational drug commonly known as "bath salts", could be more addictive than methamphetamine.Read More
FeaturedNeurosciencePsychology·August 22, 2019·4 min read‘Microdosers’ of psychedelics report improved mood, focus and creativityThose who microdose psychedelics report improved mood, greater focus, and increased creativity. A new study looks at the positive outcomes of microdosing and suggests others look at potential long-term negative consequences of using psychedelics.Read More
FeaturedNeurologyNeurosciencePsychology·April 28, 2026·7 min read43% of Antipsychotics for Seniors Start in HospitalsAntipsychotic prescriptions are "sticky," often continuing for over a year after being initiated in hospital settings.Read More
FeaturedNeurologyNeuroscience·March 6, 2026·9 min read70-Year-Old Drug Could Stop Epilepsy SeizuresScientists discover that stabilizing a single ion transporter can flip the switch from seizure activity to healthy brain inhibition.Read More
FeaturedNeurology·May 11, 2016·3 min readA ‘Communication Breakdown’ During General AnesthesiaA new study reveals the neurological mechanisms at work during ketamine anesthesia.Read More
FeaturedNeurology·April 2, 2019·2 min readA “Low Dose Aspirin” for Dementia? Drug Ready for First in-Human TestingMW-151, a new drug that blocks 'bad' inflammation in the brain is about to be tested in a new human trial. Researchers believe the new drug could help stave off dementia.Read More
FeaturedNeuroscienceOpen Neuroscience ArticlesPsychology·December 9, 2022·4 min readA Better Understanding of How the Most Commonly Used ADHD Medication WorksStudy reveals how methylphenidate interacts with cognitive control networks and attention behaviors. Methylphenidate changes spontaneous neural activity in reward and cognitive control systems in children with ADHD. The changes result in more stable sustained attention.Read More
FeaturedNeurologyNeuroscience·November 18, 2022·4 min readA Connection Between Diabetes Medications and Multiple SclerosisPeople over the age of 45 who use anti-hyperglycemic medications to control their Type 2 diabetes are at increased risk of developing multiple sclerosis. However, those who are under 45 and take anti-hyperglycemic medications are at reduced risk of MS.Read More
